{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:47:48Z","timestamp":1781142468204,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      In the absence of a vaccine,\n                      <jats:italic>Staphylococcus aureus (S. aureus)<\/jats:italic>\n                      remains a major cause of morbidity and mortality in children. Studies describing\n                      <jats:italic>S. aureus<\/jats:italic>\n                      bloodstream infection (BSI) in children in Africa remain few.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a retrospective descriptive study conducted at Red Cross War Memorial Children\u2019s Hospital (RCWMCH) in Cape Town, South Africa. All\n                      <jats:italic>S. aureus<\/jats:italic>\n                      positive blood culture results for the period 2018\u20132022 on the National Health Laboratory Service microbiology database were identified. Case records of participants with\n                      <jats:italic>S. aureus<\/jats:italic>\n                      positive blood cultures were retrieved. Demographic, clinical, antimicrobial management and participant outcome data were extracted from the case records. Continuous variables were presented as means and standard deviations or medians and interquartile ranges as appropriate. Parametric (Student t-test) and non-parametric (Wilcoxon rank sum test for independent variables) methods were used to compare continuous variables. Pearson\u2019s Chi-square or Fisher\u2019s exact tests were used to compare categorical variables. RStudio statistical computing software version 4.4.2 was used for the logistic regression analysis. Our findings were also compared with a similar study at our institution which analysed the epidemiology of Staphylococcus bloodstream infections between 2007 and 2011 (Naidoo et al. PLoS ONE 8(10):e78396, 2013).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During the 5-year study period there were 245\n                      <jats:italic>S. aureus<\/jats:italic>\n                      BSIs identified, with an overall annual incidence risk of 2.7 cases per 1000 admissions. Methicillin-resistant\n                      <jats:italic>S. aureus<\/jats:italic>\n                      (MRSA) caused 10% of the BSIs and was predominantly healthcare-associated (79.2%). Only 2.1% of participants were living with human immunodeficiency virus (HIV). However, underweight was present in 29.2% of children with\n                      <jats:italic>S. aureus<\/jats:italic>\n                      BSI. Healthcare-associated infection comprised 33.3% of all\n                      <jats:italic>S. aureus<\/jats:italic>\n                      BSIs. 70% of BSIs had an identifiable site of infection with skin and soft tissue (25%) being the commonest. All MRSA isolates were susceptible to linezolid, teicoplanin, tigecycline and vancomycin. The mortality rate within 28 days of\n                      <jats:italic>S. aureus<\/jats:italic>\n                      BSI diagnosis was 8.3%. The commonest attributable cause of death was septic shock (25%). Requiring intensive care unit (ICU) admission during a BSI, (adjusted Odds ratio (aOR): 5.4, 95% CI: 1.89\u201315.21) was associated with increased 28-day mortality rate. When compared to the 2007\u20132011 study, there has been a decline in the incidence risk of\n                      <jats:italic>S. aureus<\/jats:italic>\n                      BSI and the prevalence of healthcare-associated MRSA BSI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>S. aureus<\/jats:italic>\n                      BSI remains a major cause of morbidity and mortality in children. Admission to ICU during a BSI episode was significantly associated with 28-day mortality. Furthermore, over time changes to the epidemiology of\n                      <jats:italic>S. aureus<\/jats:italic>\n                      BSI have occurred at RCWMCH.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable (study is not a clinical trial).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12162-0","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T21:04:38Z","timestamp":1764450278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Staphylococcus aureus bloodstream infection at a referral children\u2019s hospital in Cape Town, South Africa, 2018\u20132022"],"prefix":"10.1186","volume":"26","author":[{"given":"Jombo","family":"Namushi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsah","family":"Tootla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Nuttall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Eley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"12162_CR1","doi-asserted-by":"publisher","unstructured":"Droz N, Hsia Y, Ellis S, Dramowski A, Sharlard M, Masmaci R. Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low-and middle-income countries: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2019;8(207). https:\/\/doi.org\/10.1186\/s13756-019-0673-5.","DOI":"10.1186\/s13756-019-0673-5"},{"key":"12162_CR2","doi-asserted-by":"publisher","first-page":"e20200134","DOI":"10.1542\/peds.2020-0134","volume":"146","author":"BJ McMullan","year":"2020","unstructured":"McMullan BJ, Campbell AJ, Blyth CB, McNeil C, Montgomery PC, Tong SYC, et al. Clinical management of Staphylococcus aureus bacteremia in Neonates, children and adolescents. Pediatrics. 2020;146:3: e20200134. https:\/\/doi.org\/10.1542\/peds.2020-0134.","journal-title":"Pediatrics"},{"key":"12162_CR3","doi-asserted-by":"publisher","unstructured":"Hamer DH, Darmstadt GL, Carlin JB, Zaidi AK, Yeboah-Antwi K, Saha SK, et al. Etiology of bacteremia in young infants in six countries. Paediatr Infect Dis J. 2015;34(1). https:\/\/doi.org\/10.1097\/INF.0000000000000549.","DOI":"10.1097\/INF.0000000000000549"},{"issue":"10","key":"12162_CR4","doi-asserted-by":"publisher","first-page":"e78396","DOI":"10.1371\/journal.pone.0078396","volume":"8","author":"R Naidoo","year":"2013","unstructured":"Naidoo R, Nuttall J, Whitelaw A, Eley B. Epidemiology of Staphylococcus aureus bacteraemia at a tertiary children\u2019s hospital in cape Town, South Africa. PLoS ONE. 2013;8(10):e78396. https:\/\/doi.org\/10.1371\/journal.pone.0078396.","journal-title":"PLoS ONE"},{"key":"12162_CR5","doi-asserted-by":"publisher","unstructured":"Lochan H, Pillay V, Bamford C, Nuttall J, Eley B. Bloodstream infections at a tertiary level paediatric hospital in South Africa. BMC Infect Dis, 2017;17:750. https:\/\/doi.org\/10.1186\/s12879-017-2862-2.","DOI":"10.1186\/s12879-017-2862-2"},{"key":"12162_CR6","doi-asserted-by":"publisher","unstructured":"Dramowski A, Cotton MF, Rabie H, Whitelaw A. Trends in paediatric bloodstream infections at a South African referral hospital. BMC paediatrics. 2015;15(33). Available on https:\/\/doi.org\/10.1186\/s12887-015-0354-3.","DOI":"10.1186\/s12887-015-0354-3"},{"key":"12162_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)027240","volume":"399","author":"M Naghavi","year":"2022","unstructured":"Naghavi M, Murray CJ, Ikuta KS, Sharara F, Gray A, Han C, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)027240.","journal-title":"Lancet"},{"key":"12162_CR8","doi-asserted-by":"publisher","first-page":"101267","DOI":"10.1016\/j.eclinm.2021.101267","volume":"44","author":"D Kulkarni","year":"2022","unstructured":"Kulkarni D, Wang X, Sharland E, Stansfield D, Campbell H, Nair H. The global burden of hospitalisation due to pneumonia caused by Staphylococcus aureus in the under-5 years children: a systematic review and meta-analysis. eClinicalMedicine. 2022;44:101267. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101267.","journal-title":"eClinicalMedicine"},{"key":"12162_CR9","unstructured":"American Academy of Pediatrics. Red book: 2021\u20132024 Report of the Committee on Infectious Diseases. 2021. 677-694p 32nd Edition; ISSN No. 1080\u2009\u2013\u20090131 ISBN No. 978-1-61002-521-8 eBook: 978-1-61002-522-5."},{"issue":"3","key":"12162_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1179\/1465328111Y.0000000044","volume":"32","author":"MJ Groome","year":"2012","unstructured":"Groome MJ, Albrich WC, Wadula J, Khoosal M, Madhi SA. Community-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistance. Paediatrics Int Child Health. 2012;32(3):140\u20136. https:\/\/doi.org\/10.1179\/1465328111Y.0000000044.","journal-title":"Paediatrics Int Child Health"},{"issue":"31","key":"12162_CR11","first-page":"1341","volume":"48","author":"WG Davis","year":"1974","unstructured":"Davis WG, White CE. Cloxacillin-resistant Staphylococcus aureus in a children\u2019s hospital. S Afr Med J. 1974;48(31):1341\u20134.","journal-title":"S Afr Med J"},{"key":"12162_CR12","doi-asserted-by":"crossref","unstructured":"Bamford C, Bonorchis K, Ryan A, Simpson J, Elliott E, Hoffmann R, et al. Antimicrobial susceptibility patterns of selected bacteraemic isolates from South African public sector hospitals, 2010: surveillance data. South Afr J Epidemiol Infect. 2011\u201301;26 (4):243\u2013250.","DOI":"10.1080\/10158782.2011.11441461"},{"key":"12162_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099","author":"P Musicha","year":"2017","unstructured":"Musicha P, Cornick JE, Bar-Zeev N, French N, Masase C, Denis B, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998\u20132016): A surveillance study. Lancet Infect Dis. 2017. https:\/\/doi.org\/10.1016\/S1473-3099. (17)30394-8.","journal-title":"Lancet Infect Dis"},{"key":"12162_CR14","unstructured":"Clinical laboratory standards institute, performance standards for antimicrobial susceptibility testing, 22nd ed. CLSI supplement M100. Clinical and Laboratory Standards Institute. 2022. https:\/\/www.fda.gov\/drugs\/development-resources\/tigecycline-injection-products"},{"key":"12162_CR15","first-page":"87","volume":"81","author":"MF Cotton","year":"1992","unstructured":"Cotton MF, Burger PJ, Bodenstein WJM. Bacteraemia in children in the south-western Cape \u2013 A hospital-based survey. S Afr Med J. 1992;81:87\u201390. PubMed: 1733031.","journal-title":"S Afr Med J"},{"key":"12162_CR16","first-page":"1341","volume":"48","author":"WG Davis","year":"1974","unstructured":"Davis WG, White CE. Cloxacillin-resistant Staphylococcus aureus in a children\u2019s hospital. S Afr Med J. 1974;48:1341\u20134. PubMed: 4846427.","journal-title":"S Afr Med J"},{"key":"12162_CR17","doi-asserted-by":"publisher","first-page":"e1170","DOI":"10.1016\/S2214-109X(22)00246-7","volume":"10","author":"RC Mashau","year":"2022","unstructured":"Mashau RC, Meiring ST, Dramowski A, Magobo RE, Quan VC, Perovic O, et al. Culture-confirmed neonatal bloodstream infections and meningitis in South Africa, 2014\u201319: a cross-sectional study. Lancet Glob Health. 2022;10:e1170\u201378.","journal-title":"Lancet Glob Health"},{"key":"12162_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapediatrics.2016.1477","volume":"170","author":"BJ McMullan","year":"2016","unstructured":"McMullan BJ, Bowen A, Blyth CB, Van Hal S, Korman TM, Buttery J, et al. Epidemiology and mortality of Staphylococcus aureus bacteremia in Australian and new Zealand children. JAMA Pediatr. 2016;170:10: 979\u201386. https:\/\/doi.org\/10.1001\/jamapediatrics.2016.1477.","journal-title":"JAMA Pediatr"},{"key":"12162_CR19","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1097\/INF.0000000000000907","volume":"34","author":"EC Carrascosa","year":"2015","unstructured":"Carrascosa EC, Palac\u00edn PS, Larrosa MN, Bartolom\u00e9 R, Nalda AM, Frick MA, et al. Staphylococcus aureus bacteremia in Children - Changes during eighteen years. Pediatr Infect Dis J. 2015;34:1329\u201334.","journal-title":"Pediatr Infect Dis J"},{"key":"12162_CR20","doi-asserted-by":"crossref","unstructured":"Odutola A, Bottomley C, Zaman SA, Lindsay J, Shah M, Hossain I, et al. Staphylococcus aureus bacteraemia in children of rural areas of the Gambia, 2008\u20132015. Emerging infectious diseases. 2019-04;25(4):701\u20139.","DOI":"10.3201\/eid2504.180935"},{"key":"12162_CR21","unstructured":"South African Department of Health. Guidelines for vertical transmission prevention of communicable disease. 2023. https:\/\/knowledgehub.health.gov.za%3Efiles%3E2023-09."},{"key":"12162_CR22","unstructured":"National Institute of Health and Care Excellence (NICE). Neonatal infection: antibiotics for prevention and treatment. NICE guideline. 2021. Accessed 15 May, 2024. https:\/\/www.nice.org.uk\/guidance\/ng195."},{"key":"12162_CR23","doi-asserted-by":"publisher","unstructured":"Campbell AJ, Tong SYC, Davis JS, Munro APS, Blyth CC, Bowen AC. Infectious diseases clinician\u2019s variation in the management of pediatric Staphylococcus aureus bacteraemia and equipoise for clinical trials. Front Pead. 2019;7(249). https:\/\/doi.org\/10.3389\/fped.2019.00249.","DOI":"10.3389\/fped.2019.00249"},{"issue":"3","key":"12162_CR24","doi-asserted-by":"publisher","first-page":"e20200134","DOI":"10.1542\/peds.2020-0134","volume":"146","author":"BJ McMullan","year":"2020","unstructured":"McMullan BJ, Campbell AJ, Blyth CC, et al. Clinical management of Staphylococcus aureus bacteremia in Neonates, Children, and adolescents. Pediatrics. 2020;146(3):e20200134.","journal-title":"Pediatrics"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12162-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12162-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12162-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:44:41Z","timestamp":1767627881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12162-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12162"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12162-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was approved by the Human Research Ethics Committee (HREC), Faculty of Health Sciences, University of Cape Town (HREC REF 676\/2022). The study was registered with the National Health Research Database and was also approval by the RCWMCH Research Committee (RCC 357 \/ WC_202211_031). A requirement for consent from study participants was waived by the HREC as the study used retrospective data from previous case records with no physical patient contact. The study was completed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. Consent for publication was waived as the manuscript does not contain data from any individual or images from any participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}